Xueyan Dong
No. 261 Huansha Road
Hangzhou, 310006, China
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A multicenter clinical evaluation of polymerase chain reaction coupled with quantum dot fluorescence analysis in pathogen detection for patients with suspected bloodstream infections.
Journal: Microbiology spectrum
Published: July 21, 2026
A Multicenter Clinical Evaluation of Polymerase Chain Reaction Coupled With Quantum Dot Fluorescence Analysis and Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction in the Diagnosis of Pathogens in Patients With Suspected Respiratory Tract Infections.
Journal: Journal of medical virology
Published: April 24, 2025
UTILITY OF STREM-1 BIOMARKER AND HCP GENE FOR IDENTIFICATION OF ACINETOBACTER BAUMANNII COLONIZATION AND INFECTION IN LUNG.
Journal: Shock (Augusta, Ga.)
Published: August 09, 2023
Genomic Determinants of Pathogenicity and Antimicrobial Resistance of Nosocomial Acinetobacter baumannii Clinical Isolates of Hospitalized Patients (2019-2021) from a Sentinel Hospital in Hangzhou, China.
Journal: Infection and drug resistance
Published: February 21, 2023
Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
Journal: Disease markers
Published: December 11, 2019
Serum Exosomal Long Noncoding RNAs ENSG00000258332.1 and LINC00635 for the Diagnosis and Prognosis of Hepatocellular Carcinoma.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: August 25, 2017
Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma.
Journal: Clinical chemistry and laboratory medicine
Published: April 15, 2017
Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Journal: Disease markers
Published: March 15, 2017
Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Journal: International journal of clinical and experimental medicine
Published: August 04, 2015
Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
Journal: Diagnostic pathology
Published: April 26, 2015
Last Updated: 09/26/2026